These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 18272636)

  • 21. PSA implications and medical management of prostate cancer for the primary care physician.
    Rehsia S; Shayegan B
    Can J Urol; 2012 Oct; 19 Suppl 1():28-35. PubMed ID: 23089345
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prostate cancer. Primary care providers play critical role.
    Holden J; Emery CB
    Adv Nurse Pract; 2004 Apr; 12(4):28-35; quiz 36. PubMed ID: 15101132
    [No Abstract]   [Full Text] [Related]  

  • 23. Are physicians discussing prostate cancer screening with their patients and why or why not? A pilot study.
    Guerra CE; Jacobs SE; Holmes JH; Shea JA
    J Gen Intern Med; 2007 Jul; 22(7):901-7. PubMed ID: 17549576
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Active monitoring, radical prostatectomy and radical radiotherapy in PSA-detected clinically localised prostate cancer: the ProtecT three-arm RCT.
    Hamdy FC; Donovan JL; Lane JA; Mason M; Metcalfe C; Holding P; Wade J; Noble S; Garfield K; Young G; Davis M; Peters TJ; Turner EL; Martin RM; Oxley J; Robinson M; Staffurth J; Walsh E; Blazeby J; Bryant R; Bollina P; Catto J; Doble A; Doherty A; Gillatt D; Gnanapragasam V; Hughes O; Kockelbergh R; Kynaston H; Paul A; Paez E; Powell P; Prescott S; Rosario D; Rowe E; Neal D
    Health Technol Assess; 2020 Aug; 24(37):1-176. PubMed ID: 32773013
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Prostate-specific antigen: appropriate and inappropriate use].
    Ciatto S
    Recenti Prog Med; 2003 Mar; 94(3):95-8. PubMed ID: 12677774
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Population screening for prostate cancer and emerging concepts for young men.
    Moul JW
    Clin Prostate Cancer; 2003 Sep; 2(2):87-97. PubMed ID: 15040869
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Structured Population-based Prostate-specific Antigen Screening for Prostate Cancer: The European Association of Urology Position in 2019.
    Gandaglia G; Albers P; Abrahamsson PA; Briganti A; Catto JWF; Chapple CR; Montorsi F; Mottet N; Roobol MJ; Sønksen J; Wirth M; van Poppel H
    Eur Urol; 2019 Aug; 76(2):142-150. PubMed ID: 31092338
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Which is the most appropriate diagnostic algorithm for prostate cancer screening?].
    Allepuz Losa C; Borque Fernando A; Rioja Sanz LA
    Actas Urol Esp; 2005 May; 29(5):465-72. PubMed ID: 16013791
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Screening, diagnosis, and management of prostate cancer: improving primary care outcomes.
    Goolsby MJ
    Nurse Pract; 1998 Mar; 23(3):11-4,16,21-3 passim; quiz 42-3. PubMed ID: 9560828
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Diagnostic significance of prostate specific antigen and the development of a mass screening system for prostate cancer.
    Imai K; Ichinose Y; Kubota Y; Yamanaka H; Sato J
    J Urol; 1995 Sep; 154(3):1085-9. PubMed ID: 7543604
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prostate-specific antigen.
    Ornstein DK; Pruthi RS
    Expert Opin Pharmacother; 2000 Dec; 1(7):1399-411. PubMed ID: 11249473
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prostate-Specific Antigen (PSA)-Based Population Screening for Prostate Cancer: An Evidence-Based Analysis.
    Pron G
    Ont Health Technol Assess Ser; 2015; 15(10):1-64. PubMed ID: 26366236
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prostate-specific antigen (PSA) as a possible biomarker in non-prostatic cancer: A review.
    Pérez-Ibave DC; Burciaga-Flores CH; Elizondo-Riojas MÁ
    Cancer Epidemiol; 2018 Jun; 54():48-55. PubMed ID: 29579692
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Determinants of prostate-specific antigen test use in prostate cancer screening by primary care physicians.
    Austin OJ; Valente S; Hasse LA; Kues JR
    Arch Fam Med; 1997; 6(5):453-8. PubMed ID: 9305688
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Use of prostatic specific antigen in primary care (PSA)].
    Panach-Navarrete J; Gironés-Montagud A; Sánchez-Cano E; Doménech-Pérez C; Martínez-Jabaloyas JM
    Semergen; 2017 Apr; 43(3):189-195. PubMed ID: 27344583
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Can screening for early-stage prostate cancer be rationalized?
    Jacobson JO
    Hematol Oncol Clin North Am; 1996 Jun; 10(3):549-64. PubMed ID: 8773496
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Estimating standard performance measures of opportunistic screening for prostate cancer].
    Leoni M; Falcini F; Ravaioli A; Foca F; Andalò G; Benini F; Dal Pozzo C; Ricci R; Naldoni C; Bucchi L
    Epidemiol Prev; 2008; 32(6):285-93. PubMed ID: 19353962
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Trends in Prostate-specific Antigen Screening, Prostate Biopsies, Urology Visits, and Prostate Cancer Treatments From 2000 to 2012.
    Wallner LP; Hsu JW; Loo RK; Palmer-Toy DE; Schottinger JE; Jacobsen SJ
    Urology; 2015 Sep; 86(3):498-505. PubMed ID: 26123517
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Impact of Postoperative Radiotherapy in Men with Persistently Elevated Prostate-specific Antigen After Radical Prostatectomy for Prostate Cancer: A Long-term Survival Analysis.
    Gandaglia G; Boorjian SA; Parker WP; Zaffuto E; Fossati N; Bandini M; Dell'Oglio P; Suardi N; Montorsi F; Karnes RJ; Briganti A
    Eur Urol; 2017 Dec; 72(6):910-917. PubMed ID: 28622831
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prostate-specific antigen screening: An update of physician beliefs and practices.
    Hall IJ; Rim SH; Massetti GM; Thomas CC; Li J; Richardson LC
    Prev Med; 2017 Oct; 103():66-69. PubMed ID: 28793236
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.